Working for access to quality public healthcare in South Africa since 1998
7 February 2012

MSF-SA, TAC, SECTION27 and He-Tic picket at the Consulate General of India

Members of MSF-SA, TAC, Section 27 and He-Tic will picket at the Consulate General of India this Wednesday, 8th February to voice their concerns about the anti-public health policies being pushed on India by the European Union as part of a free trade agreement being discussed  at the upcoming EU-...

7 February 2012

Open letter to the High Commissioner to India for South Africa from TAC and SECTION27

The Treatment Action Campaign and SECTION27 have written a letter to the High Commissioner for India in South Africa requesting a meeting prior to the EU-India Summit which be held on 10 February 2012. The two organisations want to discuss provisions for the scale up of intellectual property, pus...

17 November 2011

We need the Patent Pool to work

A Joint Statement by Treatment Action Campaign, Treatment Action Group, HIV i-Base, European AIDS Treatment Group and SECTION27 17 November 2011 The exorbitant price of AIDS medicines, especially antiretrovirals, has been one of the main barriers to people with HIV accessing them, especially in d...

6 September 2011

Say no to Novartis!

6 September 2011 The Treatment Action Campaign (TAC) supports the Union of India, Cancer Patients Aid Association & others in the case brought against them by the Swiss pharmaceutical company Novartis in relation to the interpretation of Section 3(d) of the Indian Patent Act. A ruling in favour o...

16 March 2011

Proposed Economic Partnership agreement with the EU raises concerns about access to medicines

After stalling for some time, negotiations for an economic partnership agreement (EPA) between the European Union (EU) on the one hand and the Southern African Customs Union (SACU), Mozambique and Angola on the other have recently restarted. According to an article published in Business Day on 10...

9 March 2011

TAC, SECTION27 and MSF South Africa call on the EU and India to stop the threats to people’s lives

The Treatment Action Campaign (TAC), SECTION27 and Médecins Sans Frontières / Doctors Without Borders (MSF) South Africa voice support for their partners across the world opposing provisions in a proposed free trade agreement (FTA) between India and the European Union (EU) that threaten the susta...

1 July 2010

Letter to the High Commissioner for India to South Africa

During the 1990s and early 2000s generic competition drove down the prices of ARVs. Without these massive price reductions, nearly a million additional people would be dead or dying now in South Africa. In 2005 many generic producing countries, including India, became TRIPS compliant. This means ...

11 September 2009

Competition Commission places condition on GSK and Aspen merger – GSK must license abacavir to generic manufacturers

GlaxoSmithKline (GSK), one of the world’s largest pharmaceutical developers, and Aspen Pharmacare, South Africa’s largest generic pharmaceutical manufacturer, intend to merge their South African operations. As part of the merger, most of GSK’s South African operations will become part of Aspen. G...